drugset / Trial / NCT07278986
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The research study is being done to assess the safety and ability of an investigational drug called CYTALUX (pafolacianine) and a special camera system for the detection of cancer in patients undergoing surgical resection for endometrial cancer.
Timeline
- Start
- 2025-10-18
- Primary completion
- 2027-10
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pafolacianine | Diagnostic / imaging agent | — | — |